Clinical Trial Update: Evaluation of ARi With OpSens SavvyWire

View source ↗

Summary

A clinical trial evaluating ARi with OpSens SavvyWire for aortic valve insufficiency has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Insufficiency

Drugs mentioned

• SavvyWire (SavvyWire guidewire)

Snippet

Sponsor: Opsens, Inc. | Conditions: Aortic Valve Insufficiency | Status: TERMINATED